SUMMARY -There are several neuromuscular disorders affecting the human being. Most of these are poorly understood and lack an effective treatment. Due to the limitation of experimental manipulation in «anima nobili», inherited neuromuscular diseases in laboratory animals constitute a valuable source of scientific information. Amongst several animal species affected by neuromuscular disorders the house mouse is of particular interest because of its small size, short pregnancy and low costs of maintanence. In the present review 20 murine mutants with diseases affecting peripheral nerves, skeletal muscles and motor end-plates are tabulated.
inherited neuromuscular diseases.
It is therefore necessary to consider the possibility of obtaining relevant information from the study of animal mutants with neuro muscular diseases 6°. If features are discovered wnich are siminar to those expressed in human disease, the mutant might become a useful model for therapeutic trials and experimental investigation which are not possible in man 52 .
Apart from man, several animal species are known to be affected by inherited disorders of muscle, motor end-plate and nerve.
These include birds (chicken, turkey and duck), small rodents (mouse and hamster) and other larger mammals (goat, pig, horse, cattle, sheep, dog, cat and mink) 48, 51, 52, 60, 62, 102 . One of the most extensively studied labo ratory animals is the mouse due to its small size, short pregnancy and relatively low costs of maintanence. These advantages allow the investigator to employ a wide range of techniques aiming to gain an accurate idea of how the disease begins, the primary sites of pathology and its evolution from the earliest clinical and patholo gical manifestation through to its full expression.
From a survey of recent publi cations concerning murine mutations (Mouse News Letter, 1986) 20 out of about 1000 genetically determined disorders affect peripheral nerves, neuromuscular junction and/or skeletal muscles ( Table 1) .
The great majority of the mutations listed on table 1 are spontaneous and transmitted as an autosomal recessive trait. In the present tabulation the criteria used for classification were the structures predominantly affected by the mutant gene. The clinical syndromes and pathological abnormalities are distinct in most of these three main groups as will be discussed below.
However in a few mutants more than one set of structures might be involved. Although no paralysis or tremor are noted there is Abnormalities not yet fully characterized: peroneal muscular atrophy (pma) mocha-2J (mh2J) muscle deficient (mdf) shiverer (shi)
1.

Disorders of the peripheral nerves
2.
Disorder of motor end-plate or neuromuscular transmission motor end-plate (med) paralyse (par)
3.
Mutants said to be affected by disorders of muscle dystrophia muscularis (dy) muscular dysgenesis (mdg) myodystrophy (myd) myotonia (mto) A2G-adr (adr) X-linked muscular dystrophy (mdx) The disease progresses from one to six months of age and may be fatal.
The pathological process consists of widespread vacuolation of motor nerve cells in brainstem and most levels of spinal cord, the result of dilatation of rough endoplasmic reticulum 3,4,12,23,36,38,83,87. Morphological and physiological evi dence of denervation of skeletal muscle has been observed. The former is represented by atrophy of fibres and conspicuous branching of preterminal axons 38 and the latter by spontaneous fibrillations, absence of miniature end-plate potentials and increased extra-junctional sensitivity to acetylcholine 57.
Therefore this mutant could be considered as a potential model for human spinal muscular atrophy 30.
Sprawling (Swl) -The sprawling mouse was identified in subsequent gene rations of mice previously used in irradiation experiments.
Affected animals are usually identifiable by 7 to 10 days of age by abnormal resting posture more marked in the hindlimbs.
Morphological studies showed that the sensory neurons are the site of primary pathology.
Deficiency of myelinated axons in the ascending tracts, spinal roots and peripheral nerves and a reduction in number of muscle spindles were also observed 29.
It seems that a genetically-induced abnormality of ganglia could be responsible for the failure of induction of sensory receptors thus accounting for the marked reduction of peripheral sensory receptors including muscle Spindles 33, 34, 95, 96. In the cribriform degeneration 49 and tortured 55 mutant mice the morphological changes have not been so extensively studied.
They both present clinically with incoordination, ataxia and behaviour abnormalities.
Some preliminary observations showed intracellular vacuolar changes in spinal cord and brainstem of the cribriform while in the tortured mutant progressive degeneration of cerebellum, spinal cord and sensory ganglia has been described. In both mutants as might be expected peripheral nerves are also affected 103.
b) Mice with disorders of myelin of peripheral nerves:
Trembler mouse (Tr) -This mutation is transmitted by a autosomal dominant gene and is expressed by spastic paralysis, convulsions and tremor 45 . Preliminary electroencephalographic studies suggested a possible cerebellar malfunction but no morphological confirmation was obtained 19 .
It is now accepted that an hereditary demyelinating neuropathy constitutes the major abnormality in the trembler mouse 5,6, 72,73,89. The electrophysiological consequences of this hypomyelinated neuropathy are the inability to conduct rapid trains of impulse with marked reduction of motor conduction velocities 74, 75 .
The pathogenesis of this disorder has been initially attri buted to a primary defect in the synthesis of myelin 73,74 but elegant nerve grafting experiments demonstrated conclusively that the neuropathy is due to a primary Schwann cell disorder 1.2.
The pathological abnormalities in skeletal muscle and motor end-plates consist of atrophy of fibres, abundant axonal sprouting and electro-physio logical evidences of denervation affecting predominantly slow-twitch muscles.
It has been suggested that the more severe involvement of slow fibres could be due to its innervation by motor units subiected to prolonged activity and therefore predominantly affected by conduction block 39,46.
Twitcher mouse (twi) -Special interest has been raised since this mutant was described as a morpho-biochemical model for Krabbe's leucodystrophv. Affected animals show arrested development, progressive weakness and tremor due to wides pread loss of myelin with the presence of multinucleated cells in central and peripheral nervous system. These abnormalities are due to severe deficiency of gatartosvlceramidase and lactosylceramidase I, thus similar to human sphingolipidosis 41,65. in the peripheral nerves enzymatically-deprived Schwann cells fail to complete synthesis of myelin 97,98,99.
The
Several etiological factors have been postulated such as deficiency of mielyn-specific proteins 26 ; a plasmalemma molecular defect in oligodendrocytes 109 and a Schwann cell dysfunction i.
c)
Peripheral nerve disorders not yet characterized:
The animals described in this group show variable degrees of abnormalities in the peripheral nervous system as part of more complex pleiotropic genetic defects. They lack, however, adequate morphological and developmental studies and will be discussed only briefly.
The peroneal muscular atrophy shows agenesis of common peroneal nerve which induces secondary atrophy of skeletal muscles of the leg 44 . In other mutations such as the mocha-2], muscle deficient and shiverer, peripheral neuropathy and shortening of internodal lengths have been reported 25,68,103.
2.
Functional and morphological disorders of motor end-plate:
Both mutants belonging to this group have devastating clinical signs of pro gressive muscle weakness, paralysis and premature death.
In the motor end-plate mutant mouse there is striking atrophy of muscle fibres and complex terminal axonal sprouting at motor end-plates al > 37 .
It was suggested that these changes were induced by a progressive loss of functional innervation 32,57 but other authors considered that the pathological process in the med mouse is a myopathy 114 or peripheral neuro pathy 92, 93 . The paralyse mutant shows progressive atrophy of motor nerve terminals with a reduction of neuromuscular transmission and eventual denervation of end-plates. The cause of such morphophysiological abnormalities remains uncertain 40.
3.
Mutants said to show primary muscle pathology:
Dystrophia muscularis (dy) -The dystrophic mouse presents with progressive weakness of axial and limb muscles and a reduced life-span. It was initially thought to be affected by a primary myopathic disorder 7,9,71,82,88,112
A few years later McComas et al. 78 it has been suggested that muscle fibres of the dystrophic mouse might be functionally denervated 7 o> 77 .
Further studies, however, demonstrated no extra-junctional sensitivity to acetylcholine, no tetrodotoxin-resistant action poten tials and normal muscle action potential in response to nerve stimulation in the dystrophic strain. Such observations indicate normal functional innervation of skeletal muscle fibres 56, 58, 59 . Although some authors point out that the muscle abnormalities in the dy mouse do not seem to be due to neural abnormalities 67,115 a t present it is not known whether the neural or muscular changes are the first to appear and whether they are causally related. Until this problem is resolved it would be unwise to use this mutant as a model for primary muscular disease.
The muscular dysgenesis mice die at birth because of widespread failure of differentiation of cardiac and skeletal muscles which also induces skeleton malfortions 8,86,90,91.
The myopathic involvement in the myodystrophy mutant was only recognized a few years after its original identification 69.
Progressive episodes of muscle degeneration followed by regeneration constitute the principal pathology but abnormalities in the spinal roots similar to those observed in the dystrophic mouse have been reported 55,
The myotonic and the A2G-adr mutant mice lack compre hensive investigations of the skeletal muscles and nervous system. The first was assessed only electrophysiologically and showed widespread myotonic discharges while the second was reported to have a possible biochemical defect of muscle fibres 110,111.
X-linked muscular dystrophy
(mdx) -The mdx mutant mouse was first observed during a survey of genetic variations of pyruvate kinase in the mouse 22 . Further studies showed that the gene defect in the mdx mutant is in the X-chromosome in a region similar to human muscular dystrophy of the Duchenne type. Affected mice have high serum levels of this enzyme and although showing little disability they have widespread and severe muscle disease.
Preliminary morphological studies were restricted only to the analysis of muscle pathology and showed that muscle necrosis was followed by regeneration with little impairment of function 22, 27, 64, 105 . Recent studies by Torres and Duchen 106,107 demonstrated that significant ultrastructural abnormalities were present in the mdx as early as 1 day of age consisting of streaming of Z-line material followed by segmental necrosis and regeneration. Further more the disease was progressive, initially affecting proximal muscle groups but in 2-3 months most muscles were abnormal. At this stage affected muscles showed marked variation in fibre size and diameter with little increase in endomysial connec tive tissue or fat infiltration.
There was no inflammation and the heart and eye muscles were normal. Quantitative and qualitative studies of peripheral nerves showed no abnormalities and the nerve terminals were unaffected but there was a reduction in the number and depth of post-synaptic folds at motor end-plates.
These authors concluded that the mdx mouse has a primary muscle disease with a total absence of structural pathology in either central or peripheral nervous systems.
A summary of the main genetic and clinical characteristics of all the murine mutants which have been described above is presented in table 2 while in table 3 Conclusions -It is relevant to note the wide variability of inherited diseases of skeletal muscle and nerves affecting the house mouse with clinical manifestations, evolution and pathological features in many ways similar to those of human disorders. However it seems unrealistic to look at animal models as exact counterparts of human neuromuscular diseases.
A more wise approach would be to study those features of animal models which are shared with inherited human disorders aiming to find a fundamental abnormality at cellular level and to understand the common manifes tations that arise from these genetic abnormalities.
